DK0824696T3 - Fremgangsmåde og kit til at forudsige den terapeutiske reaktion på et medikament mod en malign tumor - Google Patents

Fremgangsmåde og kit til at forudsige den terapeutiske reaktion på et medikament mod en malign tumor

Info

Publication number
DK0824696T3
DK0824696T3 DK96919762T DK96919762T DK0824696T3 DK 0824696 T3 DK0824696 T3 DK 0824696T3 DK 96919762 T DK96919762 T DK 96919762T DK 96919762 T DK96919762 T DK 96919762T DK 0824696 T3 DK0824696 T3 DK 0824696T3
Authority
DK
Denmark
Prior art keywords
tumour
cells
drug
therapeutic response
sample
Prior art date
Application number
DK96919762T
Other languages
Danish (da)
English (en)
Inventor
Leif Hakansson
Annika Hakansson
Bertil Gustafsson
Original Assignee
Landstinget I Oestergoetland
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Landstinget I Oestergoetland filed Critical Landstinget I Oestergoetland
Application granted granted Critical
Publication of DK0824696T3 publication Critical patent/DK0824696T3/da

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56966—Animal cells
    • G01N33/56972—White blood cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5091—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing the pathological state of an organism
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Cell Biology (AREA)
  • Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Biotechnology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Physiology (AREA)
  • Zoology (AREA)
  • Virology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK96919762T 1995-05-12 1996-05-10 Fremgangsmåde og kit til at forudsige den terapeutiske reaktion på et medikament mod en malign tumor DK0824696T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9501782A SE9501782D0 (sv) 1995-05-12 1995-05-12 Method of predicting the therapeutic response of a drug against a malignant tumour
PCT/EP1996/002007 WO1996035949A1 (en) 1995-05-12 1996-05-10 Method and kit for predicting the therapeutic response of a drug against a malignant tumour

Publications (1)

Publication Number Publication Date
DK0824696T3 true DK0824696T3 (da) 2001-01-02

Family

ID=20398299

Family Applications (1)

Application Number Title Priority Date Filing Date
DK96919762T DK0824696T3 (da) 1995-05-12 1996-05-10 Fremgangsmåde og kit til at forudsige den terapeutiske reaktion på et medikament mod en malign tumor

Country Status (12)

Country Link
US (1) US6114128A (el)
EP (1) EP0824696B1 (el)
JP (1) JPH11504715A (el)
AT (1) ATE196688T1 (el)
CA (1) CA2215627A1 (el)
DE (1) DE69610496T2 (el)
DK (1) DK0824696T3 (el)
ES (1) ES2151665T3 (el)
GR (1) GR3034891T3 (el)
PT (1) PT824696E (el)
SE (1) SE9501782D0 (el)
WO (1) WO1996035949A1 (el)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6087090A (en) * 1997-02-25 2000-07-11 Celtrix Pharmaceuticals, Inc. Methods for predicting drug response
US5824467A (en) * 1997-02-25 1998-10-20 Celtrix Pharmaceuticals Methods for predicting drug response
US20030096237A1 (en) * 2000-08-28 2003-05-22 Ulrich Certa Determination of the ability of patients to respond to a tumor treatment
SE0402536D0 (sv) 2004-10-20 2004-10-20 Therim Diagnostica Ab Immunoregulation in cancer, chronic inflammatory and autoimmune diseases
SG10201406457VA (en) 2009-10-19 2014-11-27 Rostaquo S P A Methods and systems for pharmacogenomic treatment of cardiovascular conditions
WO2012024236A1 (en) * 2010-08-14 2012-02-23 Biogen Idec Ma Inc. LTβR BLOCKADE: METHODS FOR OPTIMIZING THERAPEUTIC RESPONSIVENESS OF PATIENTS

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5426029A (en) * 1986-03-31 1995-06-20 T Cell Diagnostics, Inc. Therapeutic and diagnostic methods using leukocyte surface antigens
CA1296622C (en) * 1986-08-12 1992-03-03 Jeffrey E. Anderson Method and apparatus for automated assessment of the immunoregulatory status of the mononuclear leukocyte immune system

Also Published As

Publication number Publication date
SE9501782D0 (sv) 1995-05-12
DE69610496T2 (de) 2001-05-10
CA2215627A1 (en) 1996-11-14
EP0824696A1 (en) 1998-02-25
ATE196688T1 (de) 2000-10-15
DE69610496D1 (de) 2000-11-02
PT824696E (pt) 2001-03-30
US6114128A (en) 2000-09-05
EP0824696B1 (en) 2000-09-27
GR3034891T3 (en) 2001-02-28
WO1996035949A1 (en) 1996-11-14
JPH11504715A (ja) 1999-04-27
ES2151665T3 (es) 2001-01-01

Similar Documents

Publication Publication Date Title
Edwards Immunologic investigations of meningococcal disease: I. Group-specific Neisseria meningitidis antigens present in the serum of patients with fulminant meningococcemia
Kolk et al. Production and characterization of monoclonal antibodies to Mycobacterium tuberculosis, M. bovis (BCG) and M. leprae.
Shin et al. Monocytoid B-cell lymphoma in patients with Sjögren's syndrome: a clinicopathologic study of 13 patients
MX9801687A (es) Compuestos y metodos para el diagnostico de tuberculosis.
DE69735294D1 (de) Spezifische monoklonale antikörperfür die extrazelluläre domäne von protasta-spezifischem membranantigen
EP0852004A2 (en) MULTIPLEXED ANALYSIS OF CLINICAL SPECIMENS
NZ518363A (en) Elisa for vascular endothelial growth factor using monoclonal and polyclonal antibodies
WO2005034008A3 (en) A method of anonymous medical testing and providing the patient with the test results
DE69841164D1 (de) Sphingosin-1-phosphat-lyase polypeptide, polynukleotide und modulierende mitteln, und verfahren zu deren verwendung
AU7260496A (en) A method and diagnostic test kit for use in aiding the diagnosis of fibromyyalgia and chronic fatigue syndrome (CFS)
EP1102988B8 (de) Verfahren zur bestimmung der immunabwehraktivität des blutes sowie testkit hierfür
Bloom et al. In vitro methods in cell-mediated immunity: a progress report
SE8701905L (sv) Foerfarande och kit foer diagnos av iga-nefropati
DK0824696T3 (da) Fremgangsmåde og kit til at forudsige den terapeutiske reaktion på et medikament mod en malign tumor
DE69839876D1 (de) Prostat-spezifisches-antigenformen und verfahren zu ihrer bestimmung
Armitage et al. Normal and certain leukaemic B cells express IL-2 receptors without in vitro activation.
Emmitt et al. Crossed immunoelectrophoresis: qualitative and quantitative considerations
Stevenson et al. Monoclonal immunoglobulin light chain in urine of patients with B lymphocytic disease: its source and use as a diagnostic aid
Nicolson et al. Growth of rat mammary adenocarcinoma cells in semisolid clonogenic medium not correlated with spontaneous metastatic behavior: heterogeneity in the metastatic, antigenic, enzymatic, and drug sensitivity properties of cells from different sized colonies
FI862242A (fi) Monoklonala antikroppar foer ej-smaocelliga lungkraeftsvulster hos maenniska.
GR3032740T3 (en) Detection of antibody production
Otto et al. Double immunochemical screening test (hemoglobin and albumin) for the detection of occult intestinal bleeding
CA2286335A1 (en) Methods of obtaining antigens specific for fungi, antibodies for such antigens, and diagnosis of disease using such antigens and/or antibodies
SE9501780D0 (sv) Monitoring immunotherapy of malignant tumours
ATE228249T1 (de) Immuntest zum nachweis von menschlichen cytomegalovirus spezifischen igm